David González de Castro

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Alice Dewdney, David Cunningham, Josep Tabernero et al. · Journal of Clinical Oncology · 2012 · 387 citations · Full text

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

David Oscier, Matthew Rose‐Zerilli, Nils Winkelmann et al. · Blood · 2012 · 206 citations

Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia

David González de Castro, Jenny Yeung, Julia Procter et al. · Blood · 2008 · 186 citations · Full text

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

Marina Parry, Matthew Rose‐Zerilli, Viktor Ljungström et al. · Clinical Cancer Research · 2015 · 152 citations · Full text

Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers

Géraldine Perkins, Timothy A. Yap, Lorna Pope et al. · PLoS ONE · 2012 · 146 citations · Full text